California Picture - California Photography
California Picture is a collection of art photography and art photographic prints of California scenic views and wildlife.

AskBio enters patent permit contract with Pfizer for HCV therapy Asklepios BioPharmaceutical.

AskBio enters patent permit contract with Pfizer for HCV therapy Asklepios BioPharmaceutical, Inc. , a privately-possessed clinical-stage biotechnology company, today it offers entered right into a patent license agreement with Pfizer announced, Inc. Granting Pfizer access to certain proprietary gene-delivery system technologies developed by AskBio, for make use of in developing novel therapies for patients with Hepatitis C virus . HCV infection is the most common chronic blood-borne infections in the usa, with approximately 3. 2 million people infected chronically. This license represents another exemplory case of AskBio’s improvement in the development and commercialization of gene-delivery platform technology that focuses on creating value for a broad selection of therapeutic options for patients, including people that have HCV.

Glenn Mattes, Chief and President Executive Officer of Arno, stated: The EMA’s orphan-drug designation represents another essential part of our development system for AR-42 that will help us pursue its clinical development for the procedure in this rare and debilitating disease. AR-42 is currently being studied in a Stage I/IIa clinical trial in adult individuals with relapsed or refractory hematologic malignancies and solid tumors. Furthermore orphan designation by the EMA, AR-42 been designated an orphan drug by the U.S. Drug and Food Administration for the treating meningioma and schwannoma of the central nervous program; it is currently under FDA review for U.S.